Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter

Get Assistance

Get Assistance - Cox Boys
We are here to help people with CF get the insurance coverage they need. Hear how the Foundation helped the Cox family.

Join us on Facebook!  Facebook 
Follow us on Twitter!  Twitter 
  Google+ 
Subscribe to our channel on YouTube!  YouTube  


Print  

Inspire Pharmaceutical's President Christy Shaffer Receives Cystic Fibrosis Foundation's Highest Award

October 20, 2009

 CF Foundation Executive Vice President and COO Rich Mattingly introduces the Breath of Life Award recipient President and CEO of Inspire Pharmaceuticals Christy Shaffer.
CF Foundation Executive Vice President and COO C. Richard Mattingly introduces Christy Shaffer, president and CEO of Inspire Pharmaceuticals as the Breath of Life Award recipient.
The Cystic Fibrosis Foundation honored Christy L. Shaffer, Ph.D., President and CEO of Inspire Pharmaceuticals, Inc., with the Breath of Life Award for her extraordinary commitment and support of the Foundation's mission.

The Breath of Life Award is the most important recognition given to an individual or company by the Foundation each year.

“Dr. Christy Shaffer has been an extraordinary advocate for those with cystic fibrosis (CF), both through her role as President and CEO of Inspire Pharmaceuticals, as well as her tireless efforts to help the CF Foundation raise funds to support vital programs,” said C. Richard Mattingly, Executive Vice President and Chief Operating Officer of the Cystic Fibrosis Foundation. “She is truly a person of commitment, great heart and enormous kindness, and we treasure her.”

For more than a decade, Dr. Shaffer directed many efforts in the support of CF patients and research. She was the first member of the Foundation's National Corporate Leadership Council and currently serves as Board Chair of the Carolinas Chapter of the Foundation. She led Inspire in its development of denufosol tetrasodium as a promising potential early intervention treatment for CF lung disease.

Dr. Shaffer was presented the award at the 23rd annual North American Cystic Fibrosis Conference in Minneapolis, Minn.

The Cystic Fibrosis Foundation is an accredited charity of the Better Business Bureau.